Notably, CDC6 and CDT1 showed lower gDS and PubTator scores, are referred to as Tbio in Target development levels, and positively correlated with cancer-related pathways, which is worthy of further experimental exploration in RCC. The gene discussed is CDT1; the disease is renal cell carcinoma.